The pandemic caused by the Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) has quickly spread globally,
infecting millions and killing hundreds of thousands of people.
Herein, to identify potential antiviral agents, 97 natural
amide-like compounds known as alkamides and piperamides were
tested against SARS-CoV-2 main protease (Mpro) and RNA-dependent
RNA polymerase (RdRp), and the human angiotensin-converting
enzyme 2 (ACE2) using molecular docking and molecular dynamics
simulations. The docking results showed that alkamides and
dimeric piperamides from
Piper
species have a
high binding affinity and potential antiviral activity against
SARS-CoV-2. The absorption, distribution, metabolism, and
excretion (ADME) profile and Lipinski’s rule of five
showed that dimeric piperamides have druglikeness potential. The
molecular dynamics results showed that pipercyclobutanamide B
forms a complex with Mpro at a similar level of stability than
N3-I. Our overall results indicate that alkamides and
piperamides, and specifically pipercyclobutanamide B, should be
further studied as compounds with SARS-CoV-2 antiviral
properties.